{"id":"W3022223690","doi":"10.3389/fmed.2020.00162","title":"Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study","year":2020,"lang":"en","type":"article","venue":"Frontiers in Medicine","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Haukeland Universitetssjukehus; Helse- og Omsorgsdepartementet; Kavlifondet","keywords":"Medicine; Chronic fatigue syndrome; Cyclophosphamide; Internal medicine; Etiology; Encephalomyelitis; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003235245,0.00223223,0.002788684,0.0005799195,0.0004769187,0.0009252266,0.001087,0.002024194,0.004148323],"category_scores_gemma":[0.001720653,0.0008008998,0.001381396,0.0005843742,0.001591469,0.001062287,0.0003737502,0.002716779,0.001075857],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000641311,"about_ca_system_score_gemma":0.001419867,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007270246,"about_ca_topic_score_gemma":0.001215281,"domain_scores_codex":[0.9991203,0.0005119802,0.00004337065,0.0001066784,0.00006898325,0.0001487135],"domain_scores_gemma":[0.9985012,0.0004868881,0.0002738706,0.0001563187,0.0001124063,0.0004694226],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8084149,0.1158615,0.002723224,0.001476095,0.0008041553,0.0002599141,0.0002113885,0.001224915,0.01374516,0.0001848356,0.001467393,0.05362652],"study_design_scores_gemma":[0.737042,0.2586422,0.002473878,0.00004037112,0.0001235106,0.00009002067,0.0000226017,0.0003678046,0.0005231884,0.00007255272,0.000590687,0.00001131556],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869533,0.003843894,0.0008635615,0.0004247148,0.0002564504,0.00517177,0.0008879825,0.00009326424,0.001505115],"genre_scores_gemma":[0.9745091,0.004931436,0.002286468,0.001440063,0.0008117353,0.01066679,0.002270645,0.0000350564,0.00304883],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004148323,"threshold_uncertainty_score":0.01710987,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06184406887044093,"score_gpt":0.3636189585158185,"score_spread":0.3017748896453776,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}